LinkedIn




Hot Topics


Can New York End the AIDS Epidemic? (7-18-2016)

From the The Huffington Post, July 18, 2016

The Blog, by David Sandman, President & CEO, New York State Health Foundation

In July 1981—35 years ago this month—The New York Times ran a now infamous headline: “Rare Cancer Seen in 41 Homosexuals.” The story also reported, “The cause of the outbreak is unknown, and there is as yet no evidence of contagion.” It was the first news article about a mysterious new disease that came to be the HIV/AIDS epidemic. Read the full article

 

^ Return to Top


Quick News Update from OMD AIDS Institute (7-18-2016)

Posted July 18, 2016

OMD SCREENSHOT – July 18th, 2016

Follow the 21st International AIDS Conference in Durban, South Africa online from July 18-22 at http://www.aids2016.org/The-Conference-Online

Register here for this month’s Free HIV Clinical Education Webinar “Testing, Treatment, and Prevention: The Clinician’s Role in Ending the Epidemic in New York State” on Wednesday, July 20th from 12:00-1:00PM.

Join our Voluntary Provider Directories:

Congress Passes Landmark Opioid Bill – the Comprehensive Addiction and Recovery Act (CARA) – on July 14th 2016. See details here.

New Paper in The Lancet Infectious Diseases on the Hepatitis C Treatment Access Crisis can be found here (requires subscription)

 

^ Return to Top


Antibiotic Resistance Threatens Gonorrhea Treatment (07-15-2016)

Posted July 15, 2016

Resistance to azithromycin, an antibiotic used to treat gonorrhea, is emerging, according to CDC findings published today in the Morbidity and Mortality Weekly Report.

For more information, please click here.

 

^ Return to Top


HIV Training NY: New PrEP Video and Text Messaging Resources (7-14-2016)

Posted July 14, 2016

New PrEP Video and Text Messaging Resources

Dear Colleague:
The AIDS Institute is pleased to announce two new exciting resources on Pre-Exposure Prophylaxis (PrEP) for HIV.

PrEP for Sex Video Series
This series of eight videos highlights the voices of men who are currently taking PrEP to prevent HIV infection.

Honest, forthright and insightful, these videos address the following topics:

  • Is PrEP Right for Me
  • Beginning the Process
  • Affordability
  • Remembering to Take PrEP
  • Condom Use
  • Why PrEP
  • Side Effects
  • PrEP and Emotions

Some ideas on how you can use these videos:

  1. Include them in community education programs about PrEP
  2. Run the videos in a public space at your agency
  3. Share links to the videos on your website
  4. Watch them with a client
  5. Post them on your agency Facebook page or tweet about them

You can find these videos embedded on the www.prepforsex.org website or you can check them out on YouTube at: PrEP for Sex – Video Series

PrEP Text Messaging Campaign
Text PREP to 69866 for personalized advice on getting PrEP!

The New York State LGBT Health & Human Services Network (“the Network”) has created a campaign that provides education and resources around PrEP. The campaign guides users through a pre-programed, yet personalized, conversation that helps them overcome at least 1 of 3 of the major barriers New Yorkers face to accessing PrEP: cost, eligibility or drug-to-drug interactions.

New Yorkers will text PREP to 69866, and after providing demographic information, be able to select the barrier they would like to overcome. In the process of overcoming each barrier, the user is provided with positive reinforcement messaging, curated resource referrals (links to NYSDOH sites) and 3 PrEP provider referrals (based off of their zip code). Through Mobile Commons’ customer relationship management platform, The Network is able to track each user’s conversation flow and whether they are clicking the provided resource links and numbers. The Network will also be able to schedule follow-up messaging and accrue private and secured lists for future campaign launches.

You can find this campaign mentioned on the www.prepforsex.org website. Feel free to reach out to Storm Hurwitz, Health Campaigns Specialist for the Network, at shurwitz@gaycenter.org with any questions, comments or concerns.

____________________________________
To register for any course, click on the appropriate registration link and enter your account log-in information.If you do not have an account with hivtrainingny.org, you will need to sign up for one prior to registering for a course. For help in registering, please contact the NYSDOH AIDS Institute’s HIV Education and Training Program at (518) 474-3045.

 

^ Return to Top


AIDSinfo: At-a-Glance: Updated HHS Adult and Adolescent Antiretroviral Treatment Guidelines Released (7-14-2016)

Posted July 14, 2016

The AIDSinfo At-a-Glance News and Features can be viewed by clicking here.

Included are updates on the following:

 

^ Return to Top


Governor Cuomo Announces Key Milestones Achieved Towards Ending the AIDS Epidemic in NYS by the End of 2020 (7-13-2016)

Posted July 13, 2016


Governor Cuomo Announces Key Milestones Achieved Towards Ending the AIDS Epidemic in New York State by the End of 2020.

Record Low Number of New HIV Infections

10 Percent Decrease in New Yorkers with Detectable Levels of HIV

Governor Andrew M. Cuomo today announced that the State of New York is on track to reduce the number of new HIV infections to just 750 by the end of 2020 and achieve the first-ever decrease in HIV prevalence. The number of New Yorkers with HIV at detectable levels decreased by approximately 10 percent between 2013 and 2014, and as a result, two-thirds of those with diagnosed HIV now have virus levels that are undetectable. The information comes from the latest data produced by the New York State Department of Health and also shows that the number of new HIV infections has fallen to fewer than 2,500, a record low.

To read the full press release, please click here.

 

^ Return to Top


NYS Clinical Education: New Courses, This Month in HIV, Archived This Month in HIV, Ending the HIV and STI Epidemic (7-12-2016)

Posted July 12, 2016

Please click here to view the latest update from the New York State Clinical Education Initiative.

Included are updates on the following:

  • New CE Courses
  • July This Month in HIV Testing, Treatment, and Prevention: The Clinician’s Role in Ending the AIDS Epidemic in New York State
  • This Month in HIV Archived Training Sessions and Fall 2016 Schedule Now Available!
  • Save the Date! “Ending the HIV and STI Epidemic: Perspectives from ED and Urgent Care Practice”

 

^ Return to Top


Syphilis Cases Increasing Among Women of Childbearing Age in New York City (7-12-2016)

Posted July 12, 2016

Syphilis Cases Increasing Among Women of Childbearing Age in New York City

Three-quarters of female syphilis cases are in women of color

Providers advised to screen all pregnant women for syphilis at first prenatal visit and delivery, and more often if patients are believed to be at risk

July 11, 2016 – The Health Department today issued a Health Alert to providers that emphasizes the importance of testing pregnant women for syphilis as infection rates rise in New York City (NYC). Mirroring overall trends in syphilis prevalence in the United States, rates of primary and secondary syphilis among NYC women have risen 36 percent from 2014 (32 cases) to 2015 (43 cases). There were 36 cases in the first six months of 2016. The median age of women with syphilis is 26, and the women are predominantly Black or Latina (73 percent). The increase in women is notable because syphilis predominately has affected men for the past 15 years.

To read the full press release, please click here.
 

NYC DOHMH Alert # 14 – Syphilis is increasing among women of child-bearing age in New York City, 2016

Please Share this Alert with Colleagues in Obstetrics and Gynecology, Pediatrics, Adolescent Medicine, Internal Medicine, Family Medicine, Primary Care, Dermatology, Infectious Diseases, Urgent Care, and Emergency Medicine.

  • Primary and secondary syphilis cases are increasing among young women of color in New York City
  • Test for pregnancy and treat empirically for syphilis any woman with a syphilis exposure or any woman with lesions or rash suggestive of syphilis.
  • Screen all pregnant women for syphilis at first prenatal visit and delivery
  • Bicillin-LA is the only treatment for pregnant women infected with or exposed to syphilis
  • Call 347-396-7201 (Monday-Friday, 8:30am–5pm) to determine the history of syphilis testing and treatment for your patient

Dear Colleagues,

After years of low and stable rates, primary and secondary (P&S) syphilis cases among women have begun to increase in New York City. Although the number of cases is still relatively small, rates of P&S syphilis increased 36% from 2014 (32 cases) to 2015 (43 cases), and the occurrence of 36 cases in the first 6 months of 2016 suggests that the trend will continue. The women with syphilis are young (median age, 26 years) and predominantly (73%) black or Hispanic. To prevent increases in congenital syphilis (CS), providers must identify and treat women with syphilis or syphilis exposure, and all pregnant women must be screened for syphilis in accordance with New York State law (1, 2). In the past several years, provider errors have resulted in several instances of fetal demise due to CS and, in 2016, one stillbirth.

To read the full alert, please click here.

 

^ Return to Top


HEALTHQUAL in the Joint Commission Journal on Quality and Patient Safety (7-12-2016)

Posted July 12, 2016

An Update from HEALTHQUAL International: HEALTHQUAL in the Joint Commission Journal on Quality and Patient Safety

We are pleased to announce the publication of a Tool Tutorial describing HEALTHQUAL’s National Organizational Assessment now available in the July 2016 Issue of the Joint Commission Journal on Quality and Patient Safety (Volume 42 Number 7).

HEALTHQUAL developed the national organizational assessment (NOA) of core national quality management program components to support the development and maturity of sustainable national improvement work among Ministries of Health in low- and middle-income countries as part of its capacity building activities through PEPFAR.

Read More

 

^ Return to Top


Updates from AETC Program Friends & Colleagues (7-11-2016)

Posted July 11, 2016

Updates from AETC Program Friends & Colleagues are now available by clicking here.

Included are updates on the following:

  • PrEP Education for Youth-Serving Primary Care Providers Toolkit
  • HHS Announces New Actions to Combat Opioid Epidemic
  • Zika Virus: Information for Clinicians Slide Set
  • Serostatus Matters CME Program
  • Addressing Organizational Barriers to HIV Care: Lessons Learned from AIDS United’s Positive Charge Initiative (webinar) – July 19, 2016, 2:00-3:00 PM ET
  • 3rd Great Plains Area Indian Health Service Public Health Training Conference – August 4-5, 2016, Bismarck, ND
  • Awareness Days

 

^ Return to Top


Quick News Update from OMD AIDS Institute (7-11-2016)

Posted July 11, 2016

OMD SCREENSHOT – July 11th, 2016

 

^ Return to Top


PrEP Education for Youth-Serving Primary Care Providers Toolkit (7-7-2016)

Posted July 7, 2016

The Sexuality Information and Education Council of the United States (SIECUS) is pleased to release the PrEP Education for Youth-Serving Primary Care Providers Toolkit, a first of its kind resource focused on supporting primary care providers (PCPs) serving youth.

The Toolkit combines the many excellent existing resources about PrEP and HIV with new content developed by experts in the field. The Expert Work Group, convened by SIECUS, focused on addressing issues surrounding PrEP delivery and contributed to the development of this online resource to support primary care providers in educating, counseling, and offering PrEP to their young patients.

Focusing on concerns from a provider perspective and provision of care to young patients disproportionately affected by HIV, the Toolkit includes tools and resources that PCPs can use in delivering PrEP care or in learning about particular aspects of PrEP delivery to youth:

  • Clinical Tools
  • Billing for PrEP
  • HIV, Stigma, and Social Determinants of Health
  • Youth and HIV Laws and Policies
  • Additional Resources

For more information, please click here.

 

^ Return to Top


Updates from AETC Program Friends & Colleagues (7-5-2016)

Posted July 5, 2016

Updates from AETC Program Friends & Colleagues are now available by clicking here.

Included are updates on the following:

  • Updated AETC Program Description Slide Set
  • Building Patient-Centered Medical Homes for Lesbian, Gay, Bisexual, and Transgender Patients and Families (report)
  • FDA Approves Epclusa for Treatment of Chronic Hepatitis C Virus Infection
  • The Stigma of HIV Prevention (webinar) – July 11, 2016, 1:30-3:00 PM ET
  • Indian Health Service (IHS) Announces Funding Opportunity to Promote HIV/AIDS Prevention and Engagement in Care
  • Save-the-Date: Ryan White HIV/AIDS Program (RWHAP) and Pre-Exposure Prophylaxis (PrEP) Webcast – August 2, 2016, 1:00-3:00 PM ET
  • Awareness Days

 

^ Return to Top


HIV Training NY: Choosing Life: Empowerment, Actions, Results! (7-5-2016)

Posted July 5, 2016

Choosing Life: Empowerment, Actions, Results!

The CLEAR (Choosing Life: Empowerment, Actions, Results!) training has been scheduled to take place in Rochester @ CHBT on July 19-22, 2016 from 8:30 am – 4:30 pm each day.

CLEAR is an evidence-based health promotion intervention (EBI) for males and females ages 16 and older living with HIV/AIDS, and for high-risk HIV-negative individuals.

CLEAR is a client-centered program delivered one-to-one using cognitive behavior techniques to change behavior. The intervention provides clients with the skills necessary to be able to make healthy choices for their lives.

With the help of prevention counselors, CLEAR clients develop a personal life goal and an individual prevention plan, via 5 core skill sessions and 21 menu sessions in order to promote long-term behavior change.

Here is the direct registration link for CLEAR: https://hivtrainingny.org/Account/LogOn?crs=1868
____________________________________

To register for any course, click on the appropriate registration link and enter your account log-in information. If you do not have an account with hivtrainingny.org, you will need to sign up for one prior to registering for a course. For help in registering, please contact the NYSDOH AIDS Institute’s HIV Education and Training Program at (518) 474-3045.

 

^ Return to Top


AIDSinfo: At-a-Glance: FDA Updates Darunavir Labeling (7-1-2016)

Posted July 1, 2016

The AIDSinfo At-a-Glance News and Features can be viewed by clicking here.

Included are updates on the following:

 

^ Return to Top


NQC e-Newsletter: The Quality Academy Expands (7-1-2016)

Posted July 1, 2016

Please click here to view the e-Newsletter from the National Quality Center (NQC).

 

^ Return to Top


The Conspicuous Gap Between HIV Care and HIV Public Health, John G. Bartlett, MD (Medscape, June 20, 2016) (6-30-2016)

Posted June 30, 2016

The Conspicuous Gap Between HIV Care and HIV Public Health, John G. Bartlett, MD (Medscape, June 20, 2016)

 

^ Return to Top


NYC Health: Update on Zika Virus Infection in New York City (6-29-2016)

Posted June 29, 2016

2016 NYC DOHMH Advisory #16: Update on Zika Virus Infection in New York City

Please share with your colleagues in Obstetrics/Gynecology, Internal Medicine, Family Medicine, Emergency Medicine, Urgent Care, Pediatrics, Infectious Disease, and Neurology:

  • As of June 24, 2016, 233 Zika virus infections have been diagnosed among New York City residents, including 24 pregnant women.
  • Advise pregnant patients to defer travel to Zika virus-affected areas until the end of their pregnancy.
  • Take a travel history from all pregnant women and patients with Zika compatible symptoms.
  • RT-PCR testing to detect Zika virus RNA in serum and urine is now available at several commercial laboratories.
  • If testing a pregnant woman for Zika infection, serology must be performed and remains available only at NYC’s Public Health Laboratory and New York State Wadsworth Center.
  • Call the NYC Health Department at 866-692-3641 to:
    • Request Zika testing for NYC residents or assistance in interpreting test results.
    • Report Zika-positive cases diagnosed by a commercial laboratory.

To view the entire 2016 NYC DOHMH Advisory #16: Update on Zika Virus Infection in New York City, please click here.

 

^ Return to Top


NYS Medicaid Update: June (6-29-2016)

Posted June 29, 2016

Dear Medicaid Provider,

The Office of Health Insurance Programs of the New York State Department of Health recently got a new look and main page for the Medicaid Update. It can be viewed along with the newly approved June 2016 Medicaid Update and can better accommodate smaller devices.

Please find the full current issue as a PDF (Portable Document Format) file available to be downloaded at: http://www.health.ny.gov/health_care/medicaid/program/update/2016/jun16_mu.pdf

-Or-

Go straight to an article or topic that pertains to you, by using your browser, when you select from the current issue’s table of contents linked here (you may need to double-click or right-click-open-hyperlink to jump straight to the article):

 

^ Return to Top


Quick News Update from OMD AIDS Institute: Bicillin L-A (6-28-2016)

Posted June 28, 2016

Special Announcement

The only manufacturer of Bicillin L-A (penicillin G benzathine) continues to report a manufacturing delay and does not expect to return to normal supply until the middle of July, 2016. Information is available at the FDA Drug Shortage website. Penicillin G benzathine is the recommended treatment for syphilis and the only recommended treatment for pregnant women infected with or exposed to syphilis. If product supply becomes critical (supply of three weeks or less), contact the Pfizer Supply Continuity Team at 844-804-4677 for an emergency supply.

The Centers for Disease Control and Prevention (CDC) suggest the following to conserve supply:

  1. Refrain from using penicillin G benzathine to treat other infectious conditions for which other effective antimicrobials are readily available;
  2. Adhere to the recommended dosing of 2.4 million units IM of penicillin G benzathine for the treatment of primary, secondary and early latent syphilis as indicated in the 2015 CDC STD Treatment Guidelines. Additional doses to treat early syphilis infections do not enhance efficacy.
  3. Direct questions about syphilis clinical management to the Clinical Education Initiative STD Center of Excellence by calling 866-637-2342.

 

See recorded CDC Webinar Series:
Overview of the CDC Guideline for Prescribing Opioids for Chronic Pain

 

^ Return to Top


FDA Approves Epclusa for Treatment of Chronic Hepatitis C Virus Infection (6-28-2016)

Posted June 28, 2016

On June 28, 2016, FDA approved Epclusa to treat adult patients with chronic hepatitis C virus (HCV) both with and without cirrhosis (advanced liver disease). For patients with moderate to severe cirrhosis (decompensated cirrhosis), Epclusa is approved for use in combination with the drug ribavirin. Epclusa is a fixed-dose combination tablet containing sofosbuvir, a drug approved in 2013, and velpatasvir, a new drug, and is the first to treat all six major forms of HCV.

To view the full press announcement, please click here.

 

^ Return to Top


NYS Clinical Education: New CE Courses, HepCure Webinar, STD/HIV Risks & Screening (6-28-2016)

Posted June 28, 2016

Please click here to view the latest update from the New York State Clinical Education Initiative.

Included are updates on the following:

  • New CE Courses
  • Registration Now Open! The HepCure Tele-Education Webinar Series presents Hepatitis C Treatment in the Active Substance User
  • STD/HIV Risks & Screening for Black Men who have Sex with Men
  • This Month in HIV Testing, Treatment, and Prevention: The Clinician’s Role in Ending the AIDS Epidemic in New York State
  • CEI Line

 

^ Return to Top


Ryan White HIV/AIDS Program and Pre-Exposure Prophylaxis (PrEP) Program Letter (6-27-2016)

Posted June 27, 2016

HRSA HAB has released a letter in support of PrEP as a prevention tool against HIV transmission, to align with the National HIV/ AIDS Strategy: Updated to 2020 Goal 1: Reduce New Infections and calls upon federal agencies to implement PrEP within their programs. The letter encourages Ryan White HIV/AIDS Program (RWHAP) recipients and providers to leverage the RWHAP infrastructure to support PrEP services within the parameters of the RWHAP legislation.

Link to read the full letter

 

^ Return to Top


Updates from AETC Program Friends & Colleagues (6-27-2016)

Posted June 27, 2016

Updates from AETC Program Friends & Colleagues are now available by clicking here.

Included are updates on the following:

  • Ryan White HIV/AIDS Program and Pre-Exposure Prophylaxis (PrEP) Program Letter
  • HIV Health Improvement Affinity Group
  • The Afforadable Care Act (ACA) and People with HIV: An Update
  • Building Respect for LGBT Older Adults E-Learning: Supplemental Information for Staff
  • Back to the Basics: Primary and Behavioral Health Care Integration (webinar) – July 11, 2016, 2:00-3:00 PM EDT
  • HPV, Telehealth, Opioid Prescribing, and more….Public Health Webinar Series
  • 5th Annual Rural HIV Research and Training Conference – September 9-10, 2016, Savannah, GA
  • Awareness Days

 

^ Return to Top


Governor Cuomo Announces All HIV-Positive Individuals in New York City to Become Eligible For Housing, Transportation and Nutritional Support: Read Press Release (6-23-2016)

Posted June 23, 2016

Read the press release: Governor Cuomo Announces All HIV-Positive Individuals in New York City to Become Eligible for Housing, Transportation and Nutritional Support

 

^ Return to Top


NYSDOH Announces New Policy Defining Program Eligibility by HIV Status (6-23-2016)

Posted June 23, 2016

Defining Program Eligibility by HIV Status

New York State Department of Health Policy Statement, June 23, 2016

In past decades, when there was little information about HIV and AIDS, health care providers made decisions about when to initiate care and treatment for persons infected with HIV based upon the presence of certain symptoms, such as HIV-associated dementia, HIV nephropathy, and other HIV-related malignancies and conditions. In the absence of such conditions, treatment was initiated when a patient’s CD4 count fell below 350 cells/mm3 .

Today, it is common knowledge that, to achieve viral load suppression, care and treatment should begin immediately upon diagnosis of HIV. For this reason, HIV status is the current standard by which determinations are made for eligibility: to receive care and treatment in a State-designated AIDS center hospital or HIV Primary Care Program clinic; to enroll in an HIV Special Needs Plan (HIVSNP) or health home; and to participate in HIV/AIDS-related programs, such as the AIDS Adult Day Health Care Programs. Using HIV diagnosis as the standard for determining when to begin HIV care and treatment is consistent with the recommendations of the US Centers for Disease Control and Prevention.1 This message is, and has been, reflected in all communications of the New York State AIDS Institute.2

The purpose of this Policy Statement is to formally reiterate that the New York State Department of Health AIDS Institute’s clinical guidelines recommend that HIV-related care and treatment be initiated immediately upon diagnosis. Accordingly, to the extent permitted by law, the terms “clinical/symptomatic HIV illness or AIDS”, “AIDS or HIV-related illness,” and other similar terms shall mean laboratory-confirmed HIV diagnosis.

This Policy Statement aligns with Governor Andrew M. Cuomo’s Ending the AIDS Epidemic (ETE) initiative, which seeks to prevent the transmission of HIV and decrease the incidence of persons infected with HIV. The ETE initiative also includes the Governor’s recent negotiation of new legislation that will expand access to postexposure prophylaxis (PEP), as well as other legislation and initiatives focused on improving the health of currently HIV-infected persons and preventing HIV transmission in New York State.

———————————

1. The Centers for Disease Control and Prevention’s guidelines can be found at https://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-arv-guidelines/0.

2. Additional AIDS Institute guidelines can be found at http://www.hivguidelines.org/clinical-guidelines/adults/antiretroviraltherapy/#III. WHEN TO INITIATE ART.

 

^ Return to Top


Governor Cuomo Signs Legislation to Combat the Heroin and Opioid Crisis (6-22-2016)

Posted June 22, 2016

Comprehensive Legislative Package Limits Opioid Prescriptions from 30 to 7 Days, Requires Mandatory Prescriber Education on Pain Management to Stem the Tide of Addiction, Eliminates Burdensome Insurance Barriers to Treatment

Expands Supports for New Yorkers in Recovery, Increases Treatment Beds by 270 and Adds 2,335 Program Slots for Substance Use Disorder in New York

To learn more, please visit https://www.governor.ny.gov/news/video-photos-transcript-governor-cuomo-signs-legislation-combat-heroin-and-opioid-crisis

 

^ Return to Top


Introducing the New AETC National Coordinating Resource Center Website (6-22-2016)

Posted June 22, 2016

We are pleased to announce that the newly redesigned and expanded AETC NCRC website (aidsetc.org) is now LIVE! The website has been updated to meet the needs of our growing audience of healthcare professionals interested in building capacity to improve care delivery to people living with HIV and those at risk throughout the U.S. and its territories. With the extent of information available on the website this was no easy task, but in response to website user feedback, a more engaging and user-friendly site was created for new and returning visitors alike.

You’ll notice new branding images and visual identity elements have been incorporated throughout to enliven and unify the AETC Program and its grantees. Training topics have been reorganized to guide users to their destination more efficiently, and a new responsive design makes the site clear and legible from any viewing device. The website is also accessibility compliant. Our technical team monitors the site regularly to prevent and remove barriers to accessibility for people with disabilities, and advocates for content authors and producers to follow standards when writing and preparing new information for publication in all formats.

We hope that you will take some time to familiarize yourself with the new site. The AETC NCRC is committed to providing high-quality information and resources for your training needs, while improving your user experience. The site will continue to grow so please do not hesitate to contact us if you have trouble accessing any of the content, or to provide feedback about the new features. We look forward to hearing your thoughts.

 

^ Return to Top


HIV Training NY: Peer Worker Employment Opportunities LISTSERV (6-22-2016)

Posted June 22, 2016

Announcing a FREE Employment Opportunities LISTSERV for HIV, HCV and Harm Reduction Peer Workers

Due to public demand for a way to connect agencies seeking to hire Peer Workers with interested applicants, the NYS Department of Health AIDS Institute is establishing the Peer Worker Employment Opportunities LISTSERV. The LISTSERV is free of cost for both employers and Peer Workers seeking employment.

How will the LISTSERV work?

  • Employers will be invited to send information about available Peer Worker positions to the AIDS Institute at: hivet@health.ny.gov
  • Peer Workers interested in learning about available positions will sign up to participate in the LISTSERV. The names of people who sign up for the LISTSERV are never publically displayed
  • The AIDS Institute will compile the available positions and send them out by email periodically through the Peer Worker Employment Opportunities LISTSERV
  • The LISTSERV will include the following information about each available position: name of employer and location; short description of job; required qualifications; how to apply; dates when applications are due; link to agency website with the job posting

How can I sign up for the Peer Worker Employment Opportunities LISTSERV?

Peer workers (HIV/HCV/Harm Reduction) looking for employment, or anyone interested in receiving the announcements, can sign up for the LISTSERV by visiting www.hivtrainingny.org, typing their email address into the box at the bottom of the right column titled Peer Worker Employment Opportunities LISTSERV and completing the fields on the page that comes up.

Do I have to be an AIDS Institute Certified Peer Worker to join the LISTSERV?
No. Anyone may join the LISTSERV, whether you are certified, working toward certification or have no plans to ever become certified.

How will the Peer Worker Employment Opportunities LISTSERV help my agency?
If your agency has an open position for a Peer Worker, you can send information about the position to the AIDS Institute who will announce the employment opportunity via the LISTSERV. All Peer Workers who have signed up on the LISTSERV will receive the notification. This will help ensure you receive a strong pool of applicants for any open position.

How can I have my job opportunities announced via the LISTSERV?
Send the following information about the position to: hivet@health.ny.gov

  • name of employer and location;
  • short description of job;
  • required qualifications;
  • how to apply and dates when applications are due;
  • link to agency website with the posted position.

How often will LISTSERV announcements be sent out?
Announcements will be sent out within the 3rd business day of confirmed receipt of the request for posting. Please consider this when you establish dates for when applications are due.

Will the LISTSERV be only open to AIDS Institute Certified Peer Workers?
No. Anyone may join the LISTSERV whether they are currently certified, pursuing certification or never planning to pursue certification. If your agency is seeking a Certified Peer Worker, please state that when describing required qualifications.

For additional information on AIDS Institute Peer Certification, visit our website: https://www.hivtrainingny.org/Home/PeerCertification

Questions about the LISTSERV? Contact Leslie Osta at leslie.osta@health.ny.gov or 518-474-3045

 

^ Return to Top


SMAIF Supports HRSA Grant Opportunity to Address HIV Care Continuum in Southern Metropolitan Areas (6-22-2016)

Posted June 22, 2016

The south lags behind much of the rest of the nation on a number of key outcomes including viral suppression and survival among people living with HIV. To help address this, the Health Resources and Services Administration (HRSA) has announced a funding opportunity for a new program: Ryan White HIV/AIDS Program Building Care and Prevention Capacity: Addressing the HIV Care Continuum in Southern Metropolitan Areas. [READ MORE]

 

^ Return to Top


CDC Health Update: CDC Recommendations for Subsequent Zika IgM Antibody Testing (6-21-2016)

Posted June 21, 2016

CDC Recommendations for Subsequent Zika IgM Antibody Testing

Summary
Testing for Zika virus infection using real-time reverse-transcription polymerase chain reaction (rRT-PCR) molecular assays is now commercially available. When requesting Zika rRT-PCR testing from a commercial laboratory, providers should be aware that commercial laboratories performing rRT-PCR currently do not also offer Zika IgM enzyme-linked immunosorbent assay (ELISA) or confirmatory serologic testing (plaque reduction neutralization test, or PRNT). Therefore, if possible, providers should store a serum aliquot for subsequent Zika IgM ELISA testing if the rRT-PCR assay is negative. Otherwise, collection of an additional serum sample may be necessary.

To download and view a PDF of the CDC Health Update, please click here.

 

^ Return to Top


CHI: Addressing Alcohol and Drug Use: An Integral Part of Primary Care (06-20-2016)

Posted June 20, 2016

  • Unhealthy alcohol and drug use are treatable, but often go unrecognized and unaddressed in primary care.
  • Incorporate a continuum of substance use health services into your practice.
  • Use electronic health records and the clinical care team to facilitate service delivery.

The full PDF version can be accessed by clicking here.

 

^ Return to Top


Updates from AETC Program Friends & Colleagues (6-20-2016)

Posted June 20, 2016

Updates from AETC Program Friends & Colleagues are now available by clicking here.

Included are updates on the following:

  • HIV & Hepatitis Health Disparities Update: June 2016
  • HIV in the Southern United States: CDC Issue Brief and Infographic
  • AIDSVu Annual Launch (webinar) – June 24, 2016, 12:00 -1:00 PM ET
  • New Analysis of HIV Prevention Among MSM
  • HIV Cure: Where Are We Now? (webinar) – July 26, 2016, 1:00-2:30 PM ET/10:00-11:30 AM PT
  • Behavioral Health Integration: Beyond the Basics (training sessions)
  • 34th Gay and Lesbian Medical Association (GLMA) Annual Conference on LGBT Health – September 14 -17, 2016, St. Louis, Missouri
  • 2016 Transgender Health Conference: Advancing Excellence in Transgender Health – September 23-24, 2016, Boston, MA
  • Awareness Days

 

^ Return to Top


FDA HIV/AIDS Update: Updates for Prezista (Darunavir) for Use in Pregnant Women (06-17-2016)

Posted June 17, 2016

On June 17, 2016, FDA approved updates to the Prezista (darunavir) for use in pregnant women. The major changes can be viewed by clicking here.

 

^ Return to Top


AIDSinfo: At-a-Glance: Seeking Participants for AIDSinfo HIV/AIDS Guidelines App Usability Study (6-17-2016)

Posted June 17, 2016

The AIDSinfo At-a-Glance News and Features can be viewed by clicking here.

Included are updates on the following:

 

^ Return to Top


The Clinical Pathway Track of the 2016 National Ryan White Conference on HIV Care & Treatment (6-16-2016)

Posted June 16, 2016

The following announcement is on behalf of the International Antiviral Society-USA (IAS-USA) regarding the Clinical Pathway Track of the 2016 National Ryan White Conference on HIV Care & Treatment:

Dear Colleagues,

This year the Ryan White Clinical Conference is being held as a track (Clinical Pathway) at the 2016 National Ryan White Conference on HIV Care & Treatment (NRWC). The Clinical Pathway track is restricted to 400 clinical decision makers who work in Ryan White HIV/AIDS Program–funded clinics or programs. General session lectures and small-group workshops will be held August 23 to August 25, 2016. As the continuing medical education sponsor, IAS–USA is organizing the Clinical Pathway track with the AIDS Education and Training Center National Coordinating Resource Center and the Health Resources and Services Administration, HIV/AIDS Bureau.

If you are an experienced HIV clinical decision maker (ie, physician, nurse practitioner, or physician assistant) in a Ryan White HIV/AIDS Program–funded clinic or program and would like to attend the Clinical Pathway track, the application can be found here. Please note that you must first be a confirmed registrant of the NRWC to apply to attend the Clinical Pathway track. Please forward this e-mail to colleagues who may fit the criteria.

For more information about the Clinical Pathway track please visit the website. If you have any questions, you can contact us by e-mail at info@iasusa.org or by phone at 415-544-9400 during regular business hours of 8:30 AM to 5:30 PM PT.

 

^ Return to Top


AETC ShareSpot: HIV and Heart Disease – NIH Explores the Connection (6-15-2016)

Posted June 15, 2016

Heart disease among HIV-infected individuals is emerging as a major public health problem despite effective treatments that suppress viral load. People living with HIV are 50 to 100% more likely to develop heart disease, including heart attack and stroke, compared with people who do not have HIV-infection. Currently, there are no approved strategies for heart disease prevention tailored to people living with HIV. REPRIEVE, which stands for a Randomized Trial to Prevent Vascular Events in HIV, is a large-scale randomized clinical research trial looking to change that. The trial will test whether a daily dose of pitavastatin reduces the risk of heart disease among HIV-infected individuals. Providers, your client may qualify to participate in REPRIEVE if he or she:

  • Is HIV-positive
  • Is between the ages of 40 and 75
  • Has been on antiretroviral therapy (ART) for at least 6 months prior to study entry
  • Has no history of heart disease (including heart attack or stroke)
  • Is not currently using a statin drug
  • Has a low to moderate risk for developing heart disease, as determined by the American College of Cardiology/American Heart Association Risk Calculator

Read more about this clinical trial in our latest ShareSpot post “HIV and Heart Disease – NIH Explores the Connection,” by Sarah Read, MD, and Karin Klingman, MD, both from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, and consider recommending participation in this historic study to help address the growing problem of HIV-related heart disease. Visit reprievetrial.org or call 1-877-29-HEART for more information.

 

^ Return to Top


WHO: Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection (6-15-2016)

Posted June 15, 2016

Recommendations for a public health approach – Second edition

Overview
These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and the care of people living with HIV. They are structured along the continuum of HIV testing, prevention, treatment and care.
This edition updates the 2013 consolidated guidelines on the use of antiretroviral drugs following an extensive review of evidence and consultations in mid-2015, shared at the end of 2015, and now published in full in 2016. It is being published in a changing global context for HIV and for health more broadly.

Please click here for more information.

 

^ Return to Top


CDC Advisory: Alert to US Healthcare Facilities: First mcr-1 Gene in E coli Bacteria found in a Human in the US (6-14-2016)

Posted June 14, 2016

The NYC Health Department is providing this Alert from the Centers for Disease Control and Prevention regarding the first mcr-1 Gene in E. coli Bacteria found in a Human in the United States. If you suspect or confirm a case with the MCR-1 gene in a NYC resident, please call the Health Departments Provider Access Line at 1-866-692-3641.

Alert to U.S. Healthcare Facilities: First mcr-1 Gene in E. coli Bacteria found in a Human in the United States

Summary
The Centers for Disease Control and Prevention (CDC) is collaborating in a coordinated public health response to the Department of Defense (DoD) announcement on May 26 of the first mcr-1 gene found in bacteria from a human in the United States (http://aac.asm.org/content/early/2016/05/25/AAC.01103-16.full.pdf+html). Escherichia coli (E. coli) bacteria carrying the mcr-1 gene were found in a urine sample from a person in Pennsylvania with no recent travel outside of the United States who presented to a clinic with a urinary tract infection. The mcr-1 gene makes bacteria resistant to the antibiotic colistin, which is used as a last-resort drug to treat patients with infections caused by multidrug-resistant bacteria, including carbapenem-resistant Enterobacteriaceae (CRE). The mcr-1 gene exists on a plasmid, a small piece of DNA that is capable of moving from one bacterium to another, potentially spreading antibiotic resistance to other bacterial species. CDC is issuing this HAN notice as a reminder to U.S. healthcare facilities about recommendations to prevent antibiotic resistant infections and alert them to additional recommendations for detecting and reporting bacteria with the mcr-1 gene.

To download and view a PDF of the CDC Update, please click here.

 

^ Return to Top


NYS Clinical Education: New CE Courses, This Month in HIV Webinar, HIV Cure Symposium, 2nd Annual STD Conference (6-14-2016)

Posted June 14, 2016

Please click here to view the latest update from the New York State Clinical Education Initiative.

Included are updates on the following:

  • New CE Courses
  • June This Month in HIV Webinar HIV Prevention for Positives and Negatives, June 15
  • Registration Now Open! New York State 2016 HIV Cure Symposium: Connecting Research to Clinical Practice, June 20
  • 2nd Annual New York State STD Conference Finger Lake Region, June 24

 

^ Return to Top


Updates from AETC Program Friends & Colleagues (6-13-2016)

Posted June 13, 2016

Updates from AETC Program Friends & Colleagues are now available by clicking here.

Included are updates on the following:

  • Updates to Perinatal Guidelines Released
  • NJ HIVLinks – Summer 2016
  • The 2015 Youth Risk Behavior Surveillance System (YRBSS) Data Released
  • Key Issues Ahead of the International AIDS Conference in South Africa (webinar) – June 21, 2016, 10:00-11:00 AM ET
  • CDC Guideline for Prescribing Opioids for Chronic Pain (webinar) – June 22, 2016, 2:00-3:00 PM ET
  • Reducing Opioid Overdose Mortality: Role of Community-Administered Naloxone (webinar) – June 23, 2016, 12:00-1:30 PM ET
  • Real-Time Clinician Consultation Services for Substance Use Management (webinar) – June 30, 2016, 5:00-6:00 PM ET
  • Call for Papers: Special Issue on Mental Health & Substance Use Issues in HIV Infection
  • Awareness Days

 

^ Return to Top


NQC e-Newsletter: Impact of the in+care Campaign (6-9-2016)

Posted June 9, 2016

Please click here to view the e-Newsletter from the National Quality Center (NQC).

 

^ Return to Top


AETC Program Quarterly Newsletter - Summer 2016 (6-8-2016)

Posted June 8, 2016

The AETC Program Quarterly Newsletter – Summer Edition is now available. It can be viewed here, or accessed via the AETC National Coordinating Resource Center website here.

 

^ Return to Top


AIDSinfo: At-a-Glance: Updates to the HHS Perinatal Guidelines Released (6-7-2016)

Posted June 7, 2016

The AIDSinfo At-a-Glance News and Features can be viewed by clicking here.

Updates to the HHS Perinatal Guidelines Released

The Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States (Perinatal Guidelines) were updated on June 7, 2016.

Appendix B: Safety and Toxicity of Individual Antiretroviral Agents in Pregnancy and Table 7: Antiretroviral Drug Use in Pregnant HIV-Infected Women: Pharmacokinetic and Toxicity Data in Human Pregnancy and Recommendations for Use in Pregnancy were revised to incorporate new data and publications, Food and Drug Administration drug label changes, and new fixed-dose combination formulations.

In Appendix B and Table 7, updates were made to the following drugs: atazanavir, dolutegravir, emtricitabine, fosamprenavir, indinavir, lamivudine, nelfinavir, nevirapine, rilpivirine, ritonavir, saquinavir, stavudine, tenofovir disoproxil fumarate, and tipranavir.

For more information, please see What’s New in the Guidelines.
 

Seeking Participants for AIDSinfo HIV/AIDS Guidelines App Usability Study

AIDSinfo is conducting an evaluation of the recently released AIDSinfo HIV/AIDS Guidelines app. The app, which is available for iOS and Android devices, provides access to the federally approved HIV/AIDS medical practice guidelines. The purpose of the evaluation is to assess the design and functionality of the app. Results from this evaluation will shape and inform future enhancements to the app.

If you are a health care professional and would like to help evaluate the app, please click here to fill out a preliminary screener. Those who are selected to participate will be compensated.

 

^ Return to Top


Updates from AETC Program Friends & Colleagues (6-6-2016)

Posted May 31, 2016

Updates from AETC Program Friends & Colleagues are now available by clicking here.

Included are updates on the following:

  • New AIDS Education & Training Center (AETC) Program Marketing Materials
  • Updated! Drugs that Fight HIV-1: A Reference Guide for Prescription HIV-1 Medications
  • Exploring Rural and Urban Mortality Differences (webinar) – June 8, 2016, 1:00-2:00 PM ET
  • Syphilis among Men who have Sex with Men (MSM): Clinical Care and Public Health Reporting (webinar) – June 9, 2016, 2:00-3:00 PM ET
  • New Investigational Approaches to HIV Treatment (webinar) – June 14, 2016, 1:00-2:30 PM ET
  • Pre-Exposure Prophylaxis (PrEP) Listening Session: Open Call for Speakers – June 20, 2016, 1:30-3:00 PM ET
  • Genital Dermatology 101: Below-the-Belt Basics (webinar) – June 23, 2016, 3:30-4:30 PM ET
  • Connecting Recently Incarcerated People Living with HIV (PLWH) to Health Coverage and Care (webinar) – June 23, 2016, 3:00-4:15 PM ET
  • Awareness Days

 

^ Return to Top


Statement by the President on the 35th Anniversary of HIV/AIDS in America (6-5-2016)

Posted June 5, 2016

On June 5, 1981, the Centers for Disease Control and Prevention published a report on what would later be understood as the first documented cases of AIDS. The past 35 years tell a story that bends from uncertainty, fear, and loss toward resilience, innovation, and hope.

Please click here to view the entire statement.

 

^ Return to Top


New & Updated HCV Fact Sheets: Adherence, Diagnostics, & Treatment (6-5-2016)

Posted June 5, 2016

Treatment Action Group has just released a new hepatitis C fact sheet on Zepatier, and updated fact sheets on Sovaldi, Viekira Pack, Harvoni, and Daklinza with new data and treatment guidelines. They are available in English and Spanish. The full set includes:

  • adherence,
  • diagnostics, and
  • treatment (Sovaldi, Olysio, Viekira Pak, Harvoni, Daklinza, Zepatier, and ribavirin).

PDFs of our fact sheets are available at: http://www.treatmentactiongroup.org/hcv/factsheets.

 

^ Return to Top


AIDSinfo: At-a-Glance (6-3-2016)

Posted June 3, 2016

The AIDSinfo At-a-Glance News and Features can be viewed by clicking here.

Included are updates on the following:

 

^ Return to Top


NYS Medicaid Update: May (6-2-2016)

Posted June 2, 2016

Dear Medicaid Provider,

The Office of Health Insurance Programs of the New York State Department of Health has a new look and main page for the Medicaid Update. It is being released along with the newly approved May 2016 Medicaid Update and can better accommodate smaller devices.

Please find the full current issue as a PDF (Portable Document Format) file available to be downloaded at: http://www.health.ny.gov/health_care/medicaid/program/update/2016/may16_mu.pdf

-Or-

Go straight to an article or topic that pertains to you, by using your browser, when you select from the current issue’s table of contents linked here (you may need to double-click or right-click-open-hyperlink to jump straight to the article):

 

^ Return to Top


Statement from FDA Commissioner Robert Califf, M.D. on the Release of the Final Individual Patient Expanded Access Form (6-2-2016)

Posted June 2, 2016

Today, the U.S. Food and Drug Administration finalized its efforts to streamline the process used by physicians to request expanded access, often called “compassionate use,” to investigational drugs and biologics for their patients. As a physician, I understand the importance of being able to access investigational treatments for a patient when there are no other options to treat their serious disease or condition.

To view the FDA Press Announcement, please click here.

 

^ Return to Top


AETC ShareSpot: Accessibility: The Bigger Picture (6-2-2016)

Posted June 2, 2016

Providing an accessible website means that you are removing barriers for users who have limited vision, hearing, and mobility to access your information and resources. The Americans with Disabilities Act requires that you create accessible web content; however, the task of improving your website to meet the requirements and needs can seem overwhelming. A new ShareSpot post, “Accessibility: The Bigger Picture” by Mary Salome, Production Manager at the University of California San Francisco Center for HIV Information, provides strategies and tips for starting the process of improving your website. In support of this story – and to further illustrate the importance of website accessibility for all users, we developed an infographic that offers some perspective about how many adults are living with disabilities in the Unites States, and how their online experience can be improved with simple changes. Visit ShareSpot to read the full story, and look for future accessibility-related posts that will focus on making specific formats compliant, like slide presentations and PDF documents, for example.

 

^ Return to Top


HIV and HCV Archived Recordings, Albany Medical College, Division of HIV Medicine (6-1-2016)

Posted June 1, 2016

Watch Albany Medical College clinical education programs on your time.

Visit our Livestream website to view online archived recordings at your convenience. Once you are on this web page, scroll down to see all our archived recordings.

Click here to visit our Livestream website.

 

^ Return to Top


NYS Clinical Education: New CE Courses, Treatment for Hepatitis C, and More (6-1-2016)

Posted June 1, 2016

Please click here to view the latest update from the New York State Clinical Education Initiative.

Included are updates on the following:

  • New CE Courses
  • Treatment for Hepatitis C: New Tests, New Drugs, and New Recommendations, June 9
  • June This Month in HIV Webinar HIV Prevention for Positives and Negatives, June 15
  • Registration Now Open! New York State 2016 HIV Cure Symposium: Connecting Research to Clinical Practice, June 20
  • 2nd Annual New York State STD Conference Finger Lake Region, June 24
  • Talk to us! Share your ideas and needs through the CEI Needs Assessment Survey

 

^ Return to Top


HIV Training NY: NYSDOH AI Peer Certification Process - Informational Session in Harlem (6-1-2016)

Posted June 1, 2016

The New York State Department of Health AIDS Institute (AI) is pleased to announce an opportunity for those interested in Peer Certification to learn more about the process and requirements. To become certified, Peer Workers must:

  • Complete foundational/readiness training or submit a personal statement;
  • Complete 90 hours of Peer Worker training from the Peer Worker Course Catalogue;
  • Have a satisfactory supervisor’s evaluation on a 500-hour practicum;
  • Agree to follow the AI Peer Worker code of ethics; and
  • Pass a knowledge exam.

As we near closer to certifying our first round of peers, the AI Peer Certification Team is visiting sites to offer informational sessions on the process and requirements for certification, as well as answer questions for those who are in the process of being certified.

Topic: New York State Department of Health AIDS Institute Peer Certification Process – Informational Session
Date: Friday, June 10, 2016
Time: 10:30am-12:30pm
Location: Harlem Hospital, Ronald H. Brown Building – 46 West 137th St Room 3701, New York, NY 10037

https://hivtrainingny.org/Account/LogOn?crs=1888

This 2 hour presentation will provide overview of the process and requirements for AIDS Institute Certification of Peer Workers and provide a step-by step walk through of the process for submitting an application for certification. There will be time for Q&A with members of the AIDS Institute Peer Certification Team.

By the end of this webcast, participants will be able to:

  • State at least three benefits of Peer Certification
  • State the three tracks for AIDS Institute Peer Worker Certification (HIV, HCV, Harm Reduction) and who is eligible to apply for certification
  • Recall the purpose of foundational training for Peer Workers and the option of completing a personal statement in lieu of foundational training
  • Identify the core and specialized training requirements for AIDS Institute Peer Worker certification
  • Recall the requirement for signing and uploading the required Code Of Ethics attestation
  • Recall the requirement for completing a practicum or work experience and uploading a satisfactory supervisor evaluation
  • Recall the requirement for passing a knowledge test and state basic features of the testing process
  • Navigate the on-line application system to begin the process of submitting an application for certification
  • Recall resources and trainings that are available online for both peer workers, their supervisors and agency leadership

Intended Audience:
Peer workers pursuing AIDS Institute certification, supervisors of Peer Workers, and interested others.

The AI plans to schedule additional informational sessions throughout NYC and upstate. Stay tuned for more opportunities to attend a session near you.

Questions? Call 518-474-3045

 

^ Return to Top


Tools to Help Individuals Locate PrEP Prescribers (6-1-2016)

Posted June 1, 2016

More and more, individuals are learning about the potential impact of HIV pre-exposure prophylaxis (PrEP). As awareness grows, so does the number of individuals seeking providers with whom they can discuss this highly effective HIV-prevention tool. Across the country, directories and locator tools in various forms are helping to link individuals with healthcare providers who will prescribe PrEP and offer comprehensive services, such as counseling to reduce risk behavior and encourage adherence and monthly STI testing for those who use PrEP. [READ MORE]

 

^ Return to Top


World Health Assembly: Here's What you Need to Know (6-1-2016)

Posted June 1, 2016

Click here to view the International AIDS Society announcement.

 

^ Return to Top


NYC Health: Interim Zika Virus Update (5-31-2016)

Posted May 31, 2016

2016 DOHMH Advisory #15: Interim Zika Virus Update

  • One commercial diagnostic laboratory (Quest) now offers RT-PCR testing of serum for Zika virus.
  • For pregnant women and their male sex partners, providers should also call 866-692-3641 to arrange urine RT-PCR and serum antibody testing through the NYC Health Department’s Public Health Laboratory.

Dear Colleagues,

Until recently, Zika virus testing for NYC residents has only been available through the NYC Health Department’s Public Health Laboratory. One commercial laboratory (Focus Diagnostics, a subsidiary of Quest) recently began accepting serum specimens for rRT-PCR Zika testing. Providers should understand that Quest is only performing rRT-PCR on serum, not on urine. Data from CDC, NY State, and New York City indicate that urine is an essential test for the diagnosis of Zika virus infection. The virus is detectable in urine specimens for a longer period than it is in serum, as long as 29 days after symptom onset in urine compared to 7 days for serum. Most Zika cases in New York City have been diagnosed by urine. Additionally, a negative rRT-PCR on urine and/or serum cannot rule out infection and should be verified with antibody testing (serology). For women (symptomatic or asymptomatic) who were pregnant while in an affected area or who have had a potential sexual exposure to Zi ka virus, and for their male sex partners, antibody testing on serum should always be ordered, and rRT-PCR on both urine and serum are recommended.

Therefore, we advise providers:

  1. When sending specimens to Quest, also collect one serum specimen and one urine specimen to send to the Health Department’s Public Health Laboratory for urine rRT-PCR and, if necessary, serology testing.
  2. Call 1-866-692-3641 to complete the testing approval and requisition process. Refer to HAN#7 for Zika virus testing guidelines (http://www1.nyc.gov/assets/doh/downloads/pdf/cd/zika-advisory7.pdf).

Currently, the average turn-around-time from specimens being received at PHL to results being reported to providers is 3 days for serum PCR, 3 days for urine PCR, and 3 weeks for serology.
The effective turn-around-time for your specific clinic may be longer, because some clinical laboratories only send specimens to PHL at designated intervals, and some specimens have problems with labeling, packaging, or requisition forms that require resolution.

For more information on Zika virus, providers are encouraged to visit our website at http://www1.nyc.gov/site/doh/providers/reporting-and-services.page.

 

^ Return to Top


Updates from AETC Program Friends & Colleagues (5-31-2016)

Posted May 31, 2016

Updates from AETC Program Friends & Colleagues are now available by clicking here.

Included are updates on the following:

  • Billing for PrEP and Related Services
  • His Health
  • LGBT Health Training and Certificate Program
  • Collecting Sexual Orientation (SO) and Gender Identity (GI) Data in Health Centers Office Hours: June 1, 2016, 12:00-1:30 PM ET
  • Billing Effectively & Accurately for Integrated Behavioral Health Services (webinar) – June 6, 2016, 2:00-3:00 PM ET
  • Addressing Social Determinants of Health Among LGBTQ Latino(a) Young Adults (webianr) – June 22, 2016, 1:00-2:00 PM ET
  • Trainers of Consumers on Quality Plus (TCQPlus) – June 21-23, 2016, Atlanta, GA
  • Awareness Days

 

^ Return to Top


FDA Approves First Buprenorphine Implant for Treatment of Opioid Dependence (5-26-2016)

Posted May 26, 2016

The U.S. Food and Drug Administration today approved Probuphine, the first buprenorphine implant for the maintenance treatment of opioid dependence. Probuphine is designed to provide a constant, low-level dose of buprenorphine for six months in patients who are already stable on low-to-moderate doses of other forms of buprenorphine, as part of a complete treatment program.

To view the FDA New Release, please click here.

 

^ Return to Top


CDC Update: Diagnostic Testing of Urine Specimens for Suspected Zika Virus Infection (5-25-2016)

Posted May 25, 2016

Please note:

  • Healthcare providers must call the NYC Health Department for approval before testing New York City residents for Zika virus infection.
  • Call 1-866-692-3641 from Monday–Friday, 9am–5pm (except holidays), to obtain approval.
  • The Health Department Public Health Laboratory performs rt-PCR testing of both serum and urine specimens.

Summary
On May 13, 2016, the Centers for Disease Control and Prevention (CDC) issued interim guidance (http://www.cdc.gov/mmwr/volumes/65/wr/mm6518e1.htm) that recommends Zika virus rRT-PCR testing of urine collected less than 14 days after symptom onset, along with testing of patient-matched serum samples, for the diagnosis of suspected Zika virus infection (1). The purpose of this Health Alert Network (HAN) health update is to further disseminate information about the interim guidance to clinical and public health professionals.

To download and view a PDF of the CDC Update, please click here.

 

^ Return to Top


Updates from AETC Program Friends & Colleagues (5-23-2016)

Posted May 23, 2016

Updates from AETC Program Friends & Colleagues are now available by clicking here.

Included are updates on the following:

  • Updated Comprehensive Slide Sets: Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents
  • E-Learn Committee Webinar: Caption This! Update on Section 508 Compliance & Captioning Options
  • HIV and Hepatitis Health Disparities Update: May 2016
  • 12th Annual Women & HIV International Clinic Conference (WHICC) Tour
  • An Introduction to the What Works in Youth HIV Website (webinar) – May 26, 2016, 2:00 – 3:00 PM ET
  • HRSA HAB Funding Opportunity Announcements through the Secretary’s Minority AIDS Initiative Fund
  • Trainers of Consumers on Quality Plus (TCQPlus) – June 21-23, 2016, Atlanta, GA
  • Awareness Days

 

^ Return to Top


NYS Clinical Education: Needs Assessment Survey (5-23-2016)

Posted May 23, 2016

Please click here to view the latest update from the New York State Clinical Education Initiative.

Included are updates on the following:

  • Needs Assessment Survey

 

^ Return to Top


NQC Special Announcement: Submit a Joint Application to NQC's New Training (5-23-2016)

Posted May 23, 2016

Please click here to view the special announcement from the National Quality Center (NQC).

 

^ Return to Top


AIDSinfo: At-a-Glance (5-20-2016)

Posted May 20, 2016

The AIDSinfo At-a-Glance News and Features can be viewed by clicking here.

Included are updates on the following:

  • AIDSinfo Apps Provide Easy Access to HIV-Related Information
  • Recent HIV/AIDS News from NIAID

 

^ Return to Top


Presidential Proclamation — National Hepatitis Testing Day, 2016 (5-20-2016)

Posted May 20, 2016

In the United States, hepatitis A, B, and C are the most common types of viral hepatitis — affecting between 3.5 and 6.9 million people and claiming the lives of thousands of our fellow Americans each year. On National Hepatitis Testing Day, we reaffirm the importance of educating people about viral hepatitis, and we encourage individuals at risk for hepatitis B and hepatitis C to get tested. [READ MORE]

 

^ Return to Top


Introducing New Viral Hepatitis Website (5-20-2016)

Posted May 20, 2016

We are pleased to launch a new HHS viral hepatitis website that will support our work across federal agencies and with partners across the nation to fight viral hepatitis. This is an important step in our efforts to raise greater awareness about viral hepatitis prevention, testing, care and – in the case of hepatitis C – cure, among policy makers, healthcare providers, at risk populations, and the public. [READ MORE]

 

^ Return to Top


HIV Training NY: AI Peer Certification Online Exam and Supervisor Evaluation Now Available (5-18-2016)

Posted May 18, 2016

AI Peer Certification Online Exam and Supervisor Evaluation Now Available

Dear Colleague,

The New York State Department of Health AIDS Institute (AI) is pleased to announce the completion of the final pieces of the online application for certification. The online knowledge exam, study guides, and supervisor evaluation are now available.

Peer Certification Knowledge Exams Now Available
Peer Workers who have started an on-line application for AI certification may now take the knowledge exam through their on-line application. When you open the application, you will find a tab on the right side of the screen labeled “Exam.” You can take the exam whenever you are ready. Although you may take the exam at any time, we recommend you complete most or all of the 90 hours of required training before taking the exam. You can access the online application here:
https://www.hivtrainingny.org/Home/PeerCertification

Completing the exam does not mean you are certified yet. Once all requirements are complete and entered into online application, you should click submit on your application to send it to the Certifying Body. The Certifying Body’s Peer Certification Coordinator will notify you when your application is successfully received and will then move on to review by the Peer Certification Review Board. The Board meets quarterly and will hold its first review of applications on June 16th, 2016. Announcements of certification will be made shortly after.

Peer Certification Exam Study Guides Available
The AI has developed Study Guides to help individuals prepare for the Peer Worker certification knowledge exam. The Study Guides are designed for each of the different certification tracks — HIV, HCV, and Harm Reduction. They are available here on our website here: https://www.hivtrainingny.org/PeerCert/StudyGuide

and via the links below:

Study Guide for Certified HIV Peer Worker Online Exam
Study Guide for Certified HCV Peer Worker Online Exam
Study Guide for Certified HR Peer Worker Online Exam

These study guides are optional resources, but provide a comprehensive summary of all the knowledge and skills that AI Certified Peer Workers should have. We expect that applicants who use the study guides will have all the information necessary to successfully complete the exam.

Peer Worker Supervisor Practicum Evaluation Form Now Available On-Line
As described above, all certified Peer Workers must complete a 500-hour supervised practicum with their sponsor agency to gain real life peer work experience and have an opportunity to practice their skills — and to see if peer work is really for them. In conjunction with the online exam launch, the Supervisor Practicum Evaluation Form is available for supervisors of peer workers who seek certification. Supervisors can complete the form and review it with their peers before the peers upload the evaluation into their online certification. The Supervisor Practicum Evaluation Form is intended to convey information about a peer worker’s ability to provide peer services and to apply Core Competencies in a workplace setting. To access the Supervisor Evaluation, click here.

Completing the exam does not mean you are certified. Once all requirements are complete and entered into online application, you should click submit on your application to send it to the Certifying Body. The Certifying Body’s Peer Certification Coordinator will notify you when your application is successfully received and will then move on to review by the Peer Certification Review Board. The Board meets quarterly and will hold its first review of applications on June 16th, 2016. Announcements of certification will be made shortly after.

Questions about the exam, supervisor evaluation or application? Call 631-444-3209 or e-mail Stephen Sebor at stonybrookpeercertification@gmail.com

Additional Questions? Call 518-474-3045 or e-mail Cassandra Kahl at cassandra.kahl@health.ny.gov.

 

^ Return to Top


HIV Training NY: Peer Certification Process: Informational Session Syracuse (5-18-2016)

Posted May 18, 2016

New York State Department of Health AIDS Institute Peer Certification Process – Informational Session in Syracuse

The New York State Department of Health AIDS Institute (AI) is pleased to announce an opportunity for those interested in Peer Certification to learn more about the process and requirements. To become certified, Peer Workers must:

  • Complete foundational/readiness training or submit a personal statement;
  • Complete 90 hours of Peer Worker training from the Peer Worker Course Catalogue;
  • Have a satisfactory supervisor’s evaluation on a 500-hour practicum;
  • Agree to follow the AI Peer Worker code of ethics; and
  • Pass a knowledge exam.

As we near closer to certifying our first round of peers, the AI Peer Certification Team is visiting sites to offer informational sessions on the process and requirements for certification, as well as answer questions for those who are in the process of being certified.

Topic: New York State Department of Health AIDS Institute Peer Certification Process – Informational Session
Date: Thursday, June 2, 2016
Time: 1:00pm- 3:00pm
Location: University United Methodist Church 1085 E Genesee St Syracuse, NY. Free parking on University Ave, designated parking lots only. Bus lines are available. Enter on University Ave, meeting will be downstairs and signs will direct you. Elevator access is available.

A small lunch will be provided from 12:00pm until 1:00pm. In order to attend the lunch hour, you must be registered for the course and email CNYhivcarenetwork@gmail.com to RSVP for lunch by May 30th. If you are joining us for lunch, please arrive promptly at noon.

To register: https://hivtrainingny.org/Account/LogOn?crs=1873

This 2 hour presentation will provide overview of the process and requirements for AIDS Institute Certification of Peer Workers and provide a step-by step walk through of the process for submitting an application for certification. There will be time for Q&A with members of the AIDS Institute Peer Certification Team.

By the end of this webcast, participants will be able to:

  • State at least three benefits of Peer Certification
  • State the three tracks for AIDS Institute Peer Worker Certification (HIV, HCV, Harm Reduction) and who is eligible to apply for certification
  • Recall the purpose of foundational training for Peer Workers and the option of completing a personal statement in lieu of foundational training
  • Identify the core and specialized training requirements for AIDS Institute Peer Worker certification
  • Recall the requirement for signing and uploading the required Code Of Ethics attestation
  • Recall the requirement for completing a practicum or work experience and uploading a satisfactory supervisor evaluation
  • Recall the requirement for passing a knowledge test and state basic features of the testing process
  • Navigate the on-line application system to begin the process of submitting an application for certification
  • Recall resources and trainings that are available online for both peer workers, their supervisors and agency leadership

Intended Audience: Peer workers pursuing AIDS Institute certification, supervisors of Peer Workers, and interested others.

The AI plans to schedule additional informational sessions throughout NYC and upstate. Stay tuned for more opportunities to attend a session near you.

Questions? Call 518-474-3045

 

^ Return to Top


NYS Clinical Education: New CE Courses, This Month in HIV, Treatment for Hepatitis C, Conference, Symposium (5-17-2016)

Posted May 17, 2016

Please click here to view the latest update from the New York State Clinical Education Initiative.

Included are updates on the following:

  • New CE Courses
  • This Month in HIV: HIV Screening and Diagnosis in New York State
  • Treatment for Hepatitis C: New Tests, New Drugs, and New Recommendations
  • Registration Now Open! Testing, Treatment, and Prevention: The Clinician’s Role in Ending the AIDS Epidemic in New York State
  • New York State 2016 HIV Cure Symposium: Connecting Research to Clinical Practice

 

^ Return to Top


Updates from AETC Program Friends & Colleagues (5-16-2016)

Posted May 16, 2016

Updates from AETC Program Friends & Colleagues are now available by clicking here.

Included are updates on the following:

  • The Same, Only Scarier: Cancer Care and the LGBT Communities (webinar) – May 20, 2016, 2:00-3:00 PM ET
  • Addressing the Behavioral Health Needs of Transgender & Gender Non-Conforming Patients (webinar) – June 13, 2016, 2:00 PM ET
  • Paying for PrEP (brochure)
  • Zika Virus Emergency Response Resources
  • Hepatitis C Virus Infection: Morbidity and Mortality Weekly Reports
  • Improvement Advisor Executive Development Program – Cambridge, MA
  • Awareness Days

 

^ Return to Top


NQC Special Announcement: Submit a Joint Application to NQC's New Training (5-13-2016)

Posted May 13, 2016

Please click here to view the special announcement from the National Quality Center (NQC).

 

^ Return to Top


NYS Clinical Education: Needs Assessment Survey (5-12-2016)

Posted May 12, 2016

Please click here to view the latest update from the New York State Clinical Education Initiative.

Included are updates on the following:

  • Needs Assessment Survey

 

^ Return to Top


NYC Health: New Zika Virus Clinical Guidance Available (5-11-2016)

Posted May 11, 2016

2016 DOHMH ADVISORY #11: New Zika Virus Clinical Guidance Available

Please share with your colleagues in Obstetrics/Gynecology, Maternal/Fetal Medicine, Internal Medicine, Family Medicine, Emergency Medicine, Urgent Care, Pediatrics, Neonatology, Infectious Disease and Neurology:

  • Clinical guidance materials are available from the NYC Health Department for evaluation of Zika virus infection in infants and counseling of pregnant women at risk for Zika virus infection.
  • A conference call on Zika virus for prenatal providers will be held on Thursday, May 12, noon-1 PM.

Dear Colleagues,

The New York City Health Department has developed guidance on clinical care for persons with or at risk for Zika virus infection. The following documents are attached, and are also available on our website:

We invite providers who care for pregnant women to participate in a conference call regarding Zika virus infection and pregnancy. The call will provide:

  • Updated information on Zika virus infection and associated birth defects
  • Details about who should be tested and how to obtain testing for these patients
  • An opportunity to ask questions

DATE/TIME: Thursday, May 12, noon
CALL-IN NUMBER: (800) 611 1148
English Call Registration Link: (https://www.surveymonkey.com/r/GD6VS2W)

For additional information on Zika virus, visit: http://www1.nyc.gov/site/doh/health/health-topics/zika-virus.page. You may also call the 866-692-3641 to discuss a specific case or ask questions about testing. We appreciate your continued diligence and cooperation as NYC responds to Zika virus.

The 2016 DOHMH ADVISORY # 11 can be found at https://a816-health30ssl.nyc.gov/sites/nychan/Lists/AlertUpdateAdvisoryDocuments/HAN_ZikaGuidanceDocWithAttachments.pdf

 

^ Return to Top


NQC e-Newsletter: Impact Report on Technical Assistance (5-11-2016)

Posted May 11, 2016

Please click here to view the e-Newsletter from the National Quality Center (NQC).

 

^ Return to Top


HRSA HIV/AIDS Funding Opportunities Announcement (5-10-2016)

Posted May 10, 2016

Please click here to review the Department of Health and Human Services, Health Resources and Services Administration HIV/AIDS funding opportunities.

 

^ Return to Top


NYC Health: Expedited Partner Therapy is an Exception to the Electronic Prescribing Mandate (5-10-2016)

Posted May 10, 2016

2016 DOHMH ADVISORY # 10: Expedited Partner Therapy is an Exception to the Electronic Prescribing Mandate

Dear Colleagues,

The New York State Commissioner of Health has waived the electronic prescribing mandate in situations requiring the use expedited partner therapy (EPT) for chlamydia. Providers can continue to use paper prescriptions for the treatment of sex partner(s) of patients infected with Chlamydia trachomatis until March 26, 2017.

EPT is the practice of providing a chlamydia-infected patient with medication or prescription to treat his or her sex partner(s) without first examining those partners. When EPT is provided in the form of a prescription, it is assumed the patient will deliver this prescription to his or her partner(s) who then fill it at a pharmacy. The New York State Commissioner acknowledges the difficulty in practicing EPT electronically and has allowed for an exception from the electronic prescribing mandate for its practice.

Guidance on how to write EPT prescriptions can be found at
https://www1.nyc.gov/assets/doh/downloads/pdf/std/ept-hcp-pharmacists-brochure.pdf

The New York State Commissioner of Health’s letter can be found at
http://www.health.ny.gov/professionals/narcotic/electronic_prescribing/docs/2016-03-16_blanket_waiver_letter.pdf

The 2016 DOHMH ADVISORY # 10 can be found at
https://a816-health30ssl.nyc.gov/sites/nychan/Lists/AlertUpdateAdvisoryDocuments/2016%20STD-EPT%20Advisory.pdf

 

^ Return to Top


NYS Health Advisory: Bicillin L-A Shortage (5-10-2016)

Posted May 10, 2016

TO: Local Health Department, Community Health Center, Urgent Care, Emergency Medicine, Family Medicine, Infectious Disease, Internal Medicine, Primary Care, Dermatology, and HIV Care

FROM: New York State Department of Health
Bureau of Sexually Transmitted Disease Prevention and Epidemiology

Health Advisory: Bicillin L-A Shortage

On April 29, 2016, the Food and Drug Administration (FDA) reported a national shortage of Bicillin L-A (penicillin G benzathine suspension) due to manufacturing issues. Benzathine penicillin G is the recommended treatment for syphilis infections and is the only treatment option for pregnant women infected with or exposed to syphilis. The FDA is working with the manufacturer to promote product availability and continues to monitor the situation. More information about Bicillin L-A availability may be found at the FDA Drug Shortage Website: http://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Penicillin%20G%20Benzathine%20%28Bicillin%20L-A%29%20Injection&st=c&tab=tabs-1.

The Centers for Disease Control and Prevention (CDC) 2015 STD Treatment Guidelines outline the recommended regimens for syphilis along with alternative regimens which are listed below. Treatment with alternative regimens must include close serologic and clinical follow up.

Primary and Secondary Syphilis

Doxycycline 100mg orally twice daily X 14 days OR
Tetracycline 500mg orally four times daily X 14 days

Latent Syphilis

Doxycycline 100mg orally twice daily X 28 days OR
Tetracycline 500mg orally four times daily X 28 days

Until normal supplies of Bicillin L-A are available, prioritize the use of Bicillin L-A for the treatment of syphilis especially in pregnant women infected with or exposed to syphilis.

Call the NYS Clinical Education Initiative’s STD Center of Excellence at 866-637-2342 to access expert medical consultation on diagnosis, treatment and management of syphilis.

Please contact the NYSDOH Bureau of Sexually Transmitted Disease Prevention and Epidemiology at (518) 474-3598 for additional assistance.

Click here to download a copy of this Health Advisory.

 

^ Return to Top


Updates from AETC Program Friends & Colleagues (5-9-2016)

Posted May 9, 2016

Updates from AETC Program Friends & Colleagues are now available by clicking here.

Included are updates on the following:

  • 12th Annual Women and HIV International Clinical Conference (program materials)
  • 7th Annual Infectious Diseases Update 2016 – June 17, 2016, 9:00 AM – 1:00 PM ET, New York, NY
  • Participants Needed! New Online Pilot Course: Supporting Recovery with Medication-Assisted Treatment (MAT)
  • Updated CDC HIV Surveillance Slide Sets, 2014
  • CDC-Funded HIV Testing: United States, Puerto Rico & US Virgin Islands, 2014
  • Awareness Days

 

^ Return to Top


Quick News Update from OMD AIDS Institute (5-9-2016)

Posted May 9, 2016

OMD SCREENSHOT – May 9, 2016

 

^ Return to Top


AIDSinfo: At-a-Glance (5-6-2016)

Posted May 6, 2016

The AIDSinfo At-a-Glance News and Features can be viewed by clicking here.

Included are updates on the following:

  • Updates to the Perinatal Guidelines and the Adult and Adolescent OI Guidelines
  • AIDSinfo Releases New Consumer Fact Sheets and Infographics
  • May 18 is HIV Vaccine Awareness Day
  • May 19 is National Asian and Pacific Islander HIV/AIDS Awareness Day
  • Recent HIV/AIDS News from NIAID

 

^ Return to Top


NYC Health: Bicillin-LA (benzathine penicillin G) shortage (5-4-2016)

Posted May 4, 2016

2016 DOHMH ADVISORY # 9: Bicillin-LA (benzathine penicillin G) shortage

  • Shortages of Bicillin-LA (benzathine penicillin G) reported nationally and expected to resolve by July 2016.
  • Providers should prioritize treatment of pregnant women infected or exposed to syphilis.

Long-acting benzathine penicillin G is the standard treatment for patients infected with syphilis and the only treatment for syphilis-infected pregnant women. Due to the limited availability of this medication, we advise providers to prioritize treatment of pregnant women infected or exposed to syphilis. Additional information on this drug shortage can be found on the CDC’s website at http://www.cdc.gov/std/treatment/drugnotices/bicillinshortage.htm and on the FDA’s website at
http://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Penicillin%20G%20Benzathine%20%28Bicillin%20L-A%29%20Injection&st=c&tab=tabs-1.

Providers should continue to report all drug shortages. Information on reporting drug shortages is available at http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm142398.htm.

To download and view a PDF of the advisory, please click here.

 

^ Return to Top


Hepatitis C Kills More Americans than Any Other Infectious Disease (5-4-2016)

Posted May 4, 2016

New CDC studies underscore urgency of hepatitis C testing and treatment, especially for baby boomers

 

^ Return to Top


FDA Publishes Revised Draft Guidance for Developing Direct-Acting Antiviral Drugs for Treatment of Chronic Hep C (5-3-2016)

Posted May 3, 2016

FDA has revised a draft guidance, titled Chronic Hepatitis C Virus Infection: Developing Direct-Acting Antiviral Drugs for Treatment.

The purpose of the guidance is to assist sponsors in the clinical development of direct-acting antiviral (DAA) drugs for the treatment of chronic hepatitis C (CHC) from the pre-investigational new drug application (pre-IND) through the new drug application (NDA) and postmarketing stages.

FDA defines direct-acting hepatitis C virus (HCV) antivirals as drugs that interfere with specific steps in the HCV replication cycle through a direct interaction with the HCV genome, polyprotein,or its polyprotein cleavage products.

The guidance addresses the FDA’s current thinking regarding the overall development program and clinical trial designs to support DAA drugs.

The guidance is available on the FDA website.

To read the complete FDA update, please visit https://content.govdelivery.com/accounts/USFDA/bulletins/14713db

 

^ Return to Top


HIV Quality of Care Clinical Advisory Committee Meeting Minutes and Presentations (5-3-2016)

Posted May 3, 2016

The March New York State Department of Health AIDS Institute’s HIV Quality of Care Clinical Advisory Committee meeting minutes and presentations are available by clicking here.

 

^ Return to Top


NYS Clinical Education: New CE Courses, Conference, STD Lunch and Learn & CEI Line (5-3-2016)

Posted May 3, 2016

Please click here to view the latest update from the New York State Clinical Education Initiative.

Included are updates on the following:

  • New CE Courses
  • Last chance to register! New York State 2016 Clinical Conference on HIV and Hepatitis C: Advancing Care through Knowledge, Policy, and Implementation
  • STD Lunch and Learn Series: Congenital Syphilis
  • CEI Line

 

^ Return to Top


FDA Launches Public Education Campaign to Prevent and Reduce Tobacco Use Among LGBT Young Adults (5-2-2016)

Posted May 2, 2016

The U.S. Food and Drug Administration today announced the launch of a historic public education campaign aimed at preventing and reducing tobacco use among lesbian, gay, bisexual and transgender (LGBT) young adults ages 18-24. Of the more than 2 million LGBT young adults in the U.S., more than 800,000 smoke occasionally. The “This Free Life” campaign is designed to specifically reach the occasional or “social” smokers in the LGBT community to help prevent tobacco-related disease and the loss of tens of thousands LGBT lives to tobacco use each year. [READ MORE]

 

^ Return to Top


New PrEP Brochures from CDC: Paying for and Adherence to (5-2-2016)

Posted May 2, 2016

The following new resources are now available from the CDC.

Fact Sheets and Brochures

For more information on PrEP, please visit the CDC website at http://www.cdc.gov/hiv/risk/prep/index.html

 

^ Return to Top


CDC’s New Risk Reduction Tool: Exploring Prevention Options (5-2-2016)

Posted May 2, 2016

In December 2015, at the National HIV Prevention Conference in Atlanta, CDC launched a pilot version of a new tool that provides updated information about the many prevention methods now available. It’s called the HIV Risk Reduction Tool (HRRT). I would like to tell you how we arrived at the new messages contained in the tool and to invite you to help us continue to improve it. [READ MORE]

 

^ Return to Top


Updates from AETC Program Friends & Colleagues (5-2-2016)

Posted May 2, 2016

Updates from AETC Program Friends & Colleagues are now available by clicking here.

Included are updates on the following:

  • Updated AETC Program Design Files and Templates
  • Department of Health and Human Services Implementation Guidance to Support Certain Components of Syringe Services Programs, 2016
  • Health, United States, 2015
  • Retooling Your HIV/AIDS Organization to Compete in the Ever Evolving Healthcare Landscape (webinar) – May 10, 2016, 2:00 – 3:00 PM ET
  • Going Viral: HIV, HCV and Worker Safety in 2016 – June 16, 2016, 8:30 AM – 3:30 PM ET, Westborough, MA
  • Awareness Days

 

^ Return to Top


Shortage of Bicillin-LA (benzathine penicillin G) (4-29-2016)

Posted April 29, 2016

CDC was recently notified of difficulties in obtaining Bicillin-LA (benzathine penicillin G). Benzathine penicillin G is the recommended treatment for syphilis and the only treatment option for pregnant women infected with or exposed to syphilis. The recommended treatments for syphilis are outlined in 2015 STD Treatment Guidelines along with alternative regimens.

For more information on the shortage, see Bicillin-LA (benzathine penicillin G) Shortage.

 

^ Return to Top


May Is Hepatitis Awareness Month (4-29-2016)

Posted April 29, 2016

Each May, many partners across the federal government, including the Department of Health and Human Services (HHS) and its agencies, join with numerous non-federal and community allies to raise awareness of viral hepatitis during Hepatitis Awareness Month. The month-long observance includes national Hepatitis Testing Day on May 19th. [READ MORE]

 

^ Return to Top


WHO Issues Updated HCV Guidelines for Treatment (4-29-2016)

Posted April 29, 2016

Due to the rapid development and evolution of direct-acting viral treatments, WHO issued updated guidelines for the screening, care and treatment of individuals with chronic hepatitis C virus infection at the International Liver Congress [READ MORE].

 

^ Return to Top


NYC Health: Updated Diagnostic Testing for Zika Virus and Interpretation of Results (4-28-2016)

Posted April 28, 2016

2016 DOHMH Advisory #5 (UPDATED): Diagnostic Testing for Zika Virus and Interpretation of Results

  • As of April 28, 2016, the Public Health Laboratory will no longer routinely test specimens submitted for Zika testing from symptomatic patients for dengue and chikungunya viruses by reverse transcriptase polymerase chain reaction (RT-PCR). Clinicians should request RT-PCR testing for dengue and chikungunya viruses through a commercial laboratory.
  • Diagnosis of Zika virus infection often includes testing by both RT-PCR and serology.
  • Some patients will require a follow-up (convalescent) specimen for serologic testing to verify Zika virus infection or determine which flavivirus caused the infection.
  • Call the PAL to arrange all Zika virus testing at 1-866-692-3641.

To read the NYC DOHMH Dear Colleague Letter, please click here.

NYS Zika Virus Information Line: 1-888-364-4723

 

^ Return to Top


NYS Medicaid Update: April (4-27-2016)

Posted April 27, 2016

Dear Medicaid Provider,

The Office of Health Insurance Programs of the New York State Department of Health has approved the release of the April 2016 Medicaid Update.

Please click the link below to download the current edition.

http://www.health.ny.gov/health_care/medicaid/program/update/2016/april_16mu.pdf (PDF)

To see a list of all of the DOH Medicaid Updates, please visit http://www.health.ny.gov/health_care/medicaid/program/update/2016/

 

^ Return to Top


Updates from AETC Program Friends & Colleagues (4-26-2016)

Posted April 26, 2016

Updates from AETC Program Friends & Colleagues are now available by clicking here.

 

^ Return to Top


CDC: HIV Infection & Zika Virus (4-26-2016)

Posted April 26, 2016

To view the article, please visit http://www.cdc.gov/zika/hc-providers/hiv-zika.html

 

^ Return to Top


New CDC Fact Sheet: HIV Among Youth (4-26-2016)

Posted April 26, 2016

  • Youth aged 13 to 24 accounted for more than 1 in 5 new HIV diagnoses in 2014.
  • Young gay and bisexual males accounted for 8 in 10 HIV diagnoses among youth in 2014.
  • At the end of 2012, 44% of youth ages 18 to 24 years living with HIV did not know they had HIV.

For more information, please visit http://www.cdc.gov/hiv/group/age/youth/

 

^ Return to Top


AIDSinfo: At-a-Glance (4-22-2016)

Posted April 22, 2016

The AIDSinfo At-a-Glance News and Features can be viewed by clicking here.

Included are updates on the following:

  • AIDSinfo Education Materials Now Include Infographics
  • AIDSinfo Releases New Consumer Fact Sheets
  • CDC Updates Nonoccupational Postexposure Prophylaxis (nPEP) Guidelines
  • National Library of Medicine Announces Solicitation of Quotations for the 2016 HIV/AIDS Community Information Outreach Projects
  • Recent HIV/AIDS News

 

^ Return to Top


NYC Health: Increase in Drug Overdoses Deaths and Increased Presence of Fentanyl in NYC (4-21-2016)

Posted April 21, 2016

Increase in drug overdoses deaths and increased presence of fentanyl in New York City

 

^ Return to Top


STD Awareness Month: CDC Encourages Everyone to Talk, Test, and Treat (4-20-2016)

Posted April 20, 2016

A special note to the public from Dr. Gail Bolan, Director, Division of STD Prevention, CDC, this STD Awareness Month. April is STD Awareness Month, which gives us the opportunity to talk about sexual health in an inclusive way that speaks to individuals from all walks of life. Sex is a part of most of our lives—but sexually transmitted diseases (STDs) do not have to be one of the “facts of life.” [READ MORE]

 

^ Return to Top


HIV Training NY: Peer Certification Tests Scheduled, Study Guides Available Soon (4-19-2016)

Posted April 19, 2016

New Developments in AI Peer Certification Program  

The New York State Department of Health AIDS Institute (AI) is pleased to announce several important developments in the AI’s Peer Worker Certification effort. To become certified, Peer Workers must:

  • Complete foundational/readiness training or submit a personal statement;
  • Complete 90 hours of Peer Worker training from the Peer Worker Course   Catalogue;
  • Have a satisfactory supervisor’s evaluation on a 500-hour practicum;
  • Agree to follow the AI Peer Worker code of ethics; and
  • Pass a knowledge exam.

The three updates below pertain to the Peer Worker knowledge exam and to the Supervisor Practicum Evaluation Form.

 

Peer Certification Exam Study Guides Now Available

The AI has developed Study Guides to help individuals prepare for the Peer Worker certification knowledge exam. The Study Guides are designed for each of the different certification tracks – HIV, HCV, and Harm Reduction. They are available
here on our websit: https://www.hivtrainingny.org/Home/PeerCertification and
via the links below:

Study Guide for Certified HIV Peer Worker Online Exam

Study Guide for Certified HCV Peer Worker Online Exam

Study Guide for Certified HR Peer Worker Online Exam

These study guides are optional resources, but provide a comprehensive summary of all the knowledge and skills that AI Certified Peer Workers should have. We expect that applicants who use the study guides will have all the information necessary to successfully complete the exam.

 

Peer Certification Knowledge Exams to Be Available On-Line Starting May 2, 2016

Peer Workers who have started an on-line application for AI certification will be able to take the knowledge exam through their on-line application beginning May 1, 2016. When you open the application, you will find a tab on the right side of the screen labeled “Exam.” You can take the exam whenever you are ready after May 1. Although you may take the exam at any time, we recommend you complete most or all of the 90 hours of required training before taking the exam.

 

Peer Worker Supervisor Practicum Evaluation Form to Be Available On-Line Beginning May 2, 2016

As described above, all certified Peer Workers must complete a 500-hour supervised practicum with their sponsor agency to gain real life peer work experience and have an opportunity to practice their skills — and to see if peer work is really for them. In conjunction with the online exam launch, the Supervisor Practicum Evaluation Form will be available for supervisors of peer workers who seek certification. Supervisors can complete the form and review it with their peers before the peers upload the evaluation into their online certification. The Supervisor Practicum Evaluation Form is intended to convey information about a peer worker’s ability to provide peer services and to apply Core Competencies in a workplace setting.

The AI Peer Certification team has been working with peer workers to meet their needs and assist them throughout the certification process. We encourage anyone interested in peer certification to review the important resources at: https://www.hivtrainingny.org/Home/PeerCertification, including:

Peer Certification FAQ

Peer Certification Course Catalog

Peer Certification Code of Ethics

Course Tracker Forms

Core Competencies

 

Additional Questions? Call 518-474-3045 or e-mail Cassandra Kahl at cassandra.kahl@health.ny.gov

 

^ Return to Top


NYS Clinical Education: New CE Courses & Learning Modules, Webinar, Treatment for Hepatitis C, PrEP Payment Options (4-19-2016)

Posted April 19, 2016

Please click here to view the latest update from the New York State Clinical Education Initiative.

 

^ Return to Top


CDC Releases Updated nPEP Guidelines (4-18-2016)

Posted April 18, 2016

The Centers for Disease Control and Prevention (CDC) released Updated Guidelines for Antiretroviral Postexposure Prophylaxis After Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV, which updates and expands the 2005 U.S. Department of Health and Human Services recommendations for medical practitioners regarding nonoccupational postexposure prophylaxis (nPEP) use for persons in the United States. Updated Occupational PEP Guidelines, which address case management for persons with possible HIV exposure in health care settings, were published separately in 2013. Awareness of nPEP and its availability for both clinical providers and those who are eligible to receive it are critical to ensure that nPEP reaches those who need it most urgently.

For more information, please visit http://stacks.cdc.gov/view/cdc/38856

 

^ Return to Top


Updates from AETC Program Friends & Colleagues (4-18-2016)

Posted April 18, 2016

Updates from AETC Program Friends & Colleagues are now available by clicking here.

 

^ Return to Top


Email Announcement Archives

The HIV Clinical Guidelines Program provides subscribers with email announcements of when new guidelines are posted and existing guidelines are updated.

hivguidelines email announcement archives

hivguidelines Trends, Topics & Updates monthly mailer archives

Subscribe to hivguidelines email announcements

 

^ Return to Top


Hot Topics Archive

Please visit the Hot Topics Archive page.

^ Return to Top